News•Business Strategy
Novo Nordisk Plummets as Hims & Hers Unleashes $49 'Wegovy Clone,' Igniting Legal Firestorm in Compounding Chaos
Novo Nordisk stock dives after Hims & Hers launches a $49 Wegovy-style pill. Explore the legal chaos in compounding and the market impact.
2/6/2026
